Medical Cannabis Company Together Plans to List Subsidiary Cannabliss in North America
Cannabliss develops and manufactures smoke-free cannabis products, such as oils, candies, and cookies
Founded in 2009, Cannabliss develops and manufactures smoke-free cannabis products, such as oils, candies, and cookies. The company maintains a research and development cooperation agreement as well as a distribution center in conjunction with the Hadassah Ein Kerem hospital in Jerusalem. Together acquired the company in June for NIS 14 million (nearly $4 million).
As part of the preparation for the IPO, Together also announced Sunday that Citrine Cannabis GP of the Citrine Investment Group and Israeli accelerator and services company iCAN: Israel-Cannabis will make a joint investment of $900,000 in Cannabliss according to a company valuation of NIS 20 million ($5.67 million), in return for a 15% stake in the company.